Omega Healthcare Investors (NYSE:OHI) Stock Price Expected to Rise, Citigroup Analyst Says

Key Points

• Citigroup raised its price target on Omega Healthcare Investors from $50 to $52 and kept a buy rating, implying about a 10.61% upside from the current share price.
• Analyst coverage is mixed — the consensus is an average "Hold" rating with an average target of $48, made up of 1 Strong Buy, 5 Buy, 7 Hold and 1 Sell.
• Shares traded at $47.01, near the 52‑week high of $49.14, after quarterly results that missed EPS ($0.47 vs. $0.49) but beat on revenue (up 16.7% YoY); management set FY2026 guidance of 3.190–3.250 EPS and the stock has a market cap of about $14 billion (P/E ~22.7).

Omega Healthcare Investors (NYSE:OHI - Get Free Report) had its price objective boosted by research analysts at Citigroup from $50.00 to $52.00 in a report issued on Friday,Benzinga reports. The brokerage presently has a "buy" rating on the real estate investment trust's stock. Citigroup's target price points to a potential upside of 10.61% from the company's current price.

A number of other equities research analysts have also recently commented on the stock. Scotiabank upped their target price on shares of Omega Healthcare Investors from $45.00 to $48.00 and gave the company a "sector perform" rating in a report on Monday, March 2nd. Royal Bank Of Canada upped their target price on shares of Omega Healthcare Investors from $44.00 to $47.00 and gave the company a "sector perform" rating in a report on Tuesday, February 10th. Bank of America reaffirmed an "underperform" rating and issued a $46.00 target price (down from $52.00) on shares of Omega Healthcare Investors in a report on Tuesday, April 14th. UBS Group reissued a "buy" rating and set a $52.00 price target on shares of Omega Healthcare Investors in a report on Friday, February 6th. Finally, Wells Fargo & Company increased their price target on shares of Omega Healthcare Investors from $45.00 to $47.00 and gave the stock an "equal weight" rating in a report on Thursday, March 26th. One research analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the company's stock. According to data from MarketBeat.com, the stock presently has an average rating of "Hold" and an average target price of $48.00.

Omega Healthcare Investors Stock Performance

Shares of NYSE:OHI traded up $0.04 on Friday, reaching $47.01. The company's stock had a trading volume of 1,284,456 shares, compared to its average volume of 2,056,898. The stock's 50-day moving average is $46.38 and its two-hundred day moving average is $44.80. Omega Healthcare Investors has a 52-week low of $35.08 and a 52-week high of $49.14. The company has a debt-to-equity ratio of 0.81, a current ratio of 6.18 and a quick ratio of 5.04. The stock has a market capitalization of $14.00 billion, a P/E ratio of 22.71, a PEG ratio of 2.09 and a beta of 0.59.

Omega Healthcare Investors (NYSE:OHI - Get Free Report) last announced its earnings results on Tuesday, April 28th. The real estate investment trust reported $0.47 EPS for the quarter, missing analysts' consensus estimates of $0.49 by ($0.02). Omega Healthcare Investors had a net margin of 51.14% and a return on equity of 11.86%. The business had revenue of $322.96 million during the quarter, compared to analysts' expectations of $264.07 million. During the same period in the previous year, the company posted $0.75 earnings per share. Omega Healthcare Investors's quarterly revenue was up 16.7% on a year-over-year basis. Omega Healthcare Investors has set its FY 2026 guidance at 3.190-3.250 EPS. As a group, sell-side analysts forecast that Omega Healthcare Investors will post 3.06 EPS for the current year.

Institutional Inflows and Outflows

Several large investors have recently added to or reduced their stakes in OHI. Resources Management Corp CT ADV grew its position in Omega Healthcare Investors by 300.0% during the fourth quarter. Resources Management Corp CT ADV now owns 600 shares of the real estate investment trust's stock worth $27,000 after buying an additional 450 shares during the period. Smartleaf Asset Management LLC grew its position in Omega Healthcare Investors by 40.9% during the second quarter. Smartleaf Asset Management LLC now owns 924 shares of the real estate investment trust's stock worth $34,000 after buying an additional 268 shares during the period. Ascentis Independent Advisors acquired a new position in Omega Healthcare Investors during the first quarter worth about $35,000. Gunpowder Capital Management LLC dba Oliver Wealth Management acquired a new position in Omega Healthcare Investors during the fourth quarter worth about $37,000. Finally, Rothschild Investment LLC grew its position in Omega Healthcare Investors by 283.7% during the fourth quarter. Rothschild Investment LLC now owns 944 shares of the real estate investment trust's stock worth $42,000 after buying an additional 698 shares during the period. 65.25% of the stock is owned by hedge funds and other institutional investors.

Omega Healthcare Investors Company Profile

Omega Healthcare Investors, Inc is a real estate investment trust (REIT) that specializes in the ownership and management of healthcare-related facilities. The company's core business involves acquiring and leasing long-term care properties, including skilled nursing facilities and assisted living communities, under net lease agreements. Its portfolio is designed to provide stable, inflation-protected cash flows from operators responsible for day-to-day property management.

Founded in 1992 and headquartered in Hunt Valley, Maryland, Omega Healthcare Investors has grown its holdings to encompass hundreds of facilities across the United States, with a smaller presence in select international markets.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.